Entity Details
Primary name |
PDCD1_HUMAN |
Entity type |
UniProt |
Source |
Source Link |
Details
Accession | Q15116 |
EntryName | PDCD1_HUMAN |
FullName | Programmed cell death protein 1 |
TaxID | 9606 |
Evidence | evidence at protein level |
Length | 288 |
SequenceStatus | complete |
DateCreated | 1997-11-01 |
DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
Subcellular Location |
Cell membrane |
Domains
Show/Hide Table
Domain | Name | Category | Type |
IPR003599 | Immunoglobulin subtype | Domain | Domain |
IPR007110 | Immunoglobulin-like domain | Domain | Domain |
IPR013106 | Immunoglobulin V-set domain | Domain | Domain |
IPR013783 | Immunoglobulin-like fold | Family | Homologous superfamily |
IPR036179 | Immunoglobulin-like domain superfamily | Family | Homologous superfamily |
IPR042379 | Programmed cell death protein 1 | Family | Family |
Drugs
Show/Hide Table
Drug | Name | Source | Type |
DB05916 | CT-011 | Drugbank | biotech |
DB09035 | Nivolumab | Drugbank | biotech |
DB09037 | Pembrolizumab | Drugbank | biotech |
DB14707 | Cemiplimab | Drugbank | biotech |
DB14776 | Camrelizumab | Drugbank | biotech |
DB14892 | Spartalizumab | Drugbank | biotech |
DB14922 | Tislelizumab | Drugbank | biotech |
DB15043 | Toripalimab | Drugbank | biotech |
DB15627 | Dostarlimab | Drugbank | biotech |
DB15765 | Sintilimab | Drugbank | biotech |
DB15766 | Retifanlimab | Drugbank | biotech |
DB15767 | AMP-224 | Drugbank | biotech |
DB15768 | MEDI0680 | Drugbank | biotech |
Interactions
5 interactions